Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes - PubMed (original) (raw)
Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
D Unutmaz et al. J Exp Med. 1999.
Abstract
Lentiviral vectors have been advocated to be effective vehicles for the delivery and stable expression of genes in nondividing primary cells. However, certain cell types, such as resting T lymphocytes, are resistant to infection with HIV-1. Establishing parameters for stable gene delivery into primary human lymphocytes and approaches to overcome the resistance of resting T cells to HIV infection may permit potential gene therapy applications, genetic studies of primary cells in vitro, and a better understanding of the stages of the lentiviral life cycle. Here we demonstrate that an HIV-1-derived vector can be used for stable delivery of genes into activated human T cells as well as natural killer and dendritic cells. Remarkably, a sizeable fraction of resting T cells was stably transduced with the HIV-1 vector when cultured with the cytokine interleukin (IL)-2, IL-4, IL-7, or IL-15, or, at a lower level, with IL-6, in the absence of any other stimuli. Resting T cells stimulated with these cytokines could also be infected with replication-competent HIV-1. To test the utility of this system for performing structure-function analysis in primary T cells, we introduced wild-type as well as a mutant form of murine CD28 into human T cells and showed a requirement for the CD28 cytoplasmic domain in costimulatory signaling. The ability to stably express genes of interest in primary T cells will be a valuable tool for genetic and structure-function studies that previously have been limited to transformed cell lines. In addition, the finding that cytokine signals are sufficient to permit transduction of resting T cells with HIV may be relevant for understanding mechanism of HIV-1 transmission and pathogenesis.
Figures
Figure 1
Stable delivery and expression of genes in activated human T cell subsets through the HDV system. Purified T cells were activated with PHA and allogeneic feeder cells for 4 d and transduced with the HDV system. (A) Activated primary hCD4+ T cells were infected with HDV-EGFP viruses and GFP expression was analyzed by a FACS® 3 d after infection. (B) GFP+ T cells were sorted and expanded in culture with repeated mitogen stimulation and expression was assessed 2 wk and 4 mo after infection. (C) GFP expression in CD4+ and CD8+ T cell lines 5 d after HDV-IRES.EGFP infection. PI, post infection.
Figure 2
Transduction of myeloid cells and lymphocytes other than α/β T cells. To enrich for γ/δ+ T cells, α/β+ T cells were depleted by bead sorting and PHA lines were established as described in Materials and Methods. NK cells and B cells were positively sorted using antibodies to CD16 and CD19 respectively. NK cells were activated with 1,000 U/ml IL-2. B cells were activated as described in Materials and Methods. DC cultures were established as described by Sallusto and Lanzavecchia (44). Lymphocyte infections were done as described in Materials and Methods, whereas macrophages and DCs were infected in the absence of polybrene and at a lower MOI to prevent cytotoxicity induced by the viral supernatants. GFP was analyzed 2 wk after infection for γ/δ T cells and NK cells (gated on CD3−CD56+ cells), and 5 d after infection for B cells. Quadrants were set according to uninfected control stainings. DC infections were assessed 10 d after infection; cells were stained with PE-conjugated anti-CD14 and PercP-conjugated HLA-DR; and GFP expression was determined after gating on CD14− cells.
Figure 3
HDV-mediated transduction of both naive and memory resting T cells cultured in the presence of various cytokines. Purified resting CD4+ T cells were cultured for 4 d in media alone or with the following cytokines: IL-6 (400 U/ml), IL-2 (200 U/ml), IL-4 (20 ng/ml), IL-7 (20 ng/ml), or IL-15 (10 ng/ml). Cells were infected with HDV-IRES.GFP in the presence of cytokines for an additional 5 d and GFP expression was assessed. (A) GFP expression in resting T cells transduced in the presence of cytokines. (B) GFP expression in CD45RA+RO−CD4+ purified naive T cells transduced with HDV-IRES.EGFP.
Figure 4
Transduction efficiency of CD4+ and CD8+ resting T cells stimulated with individual or combinations of cytokines. Resting T cells were cultured and transduced with HDV-IRES.GFP as described in Fig. 3, with individual cytokines or in cytokine combinations (TNF-α was used at 50 ng/ml). Percentage of GFP+ cells was determined by FACS® analysis 5 d after infection.
Figure 5
Cell cycle entry and HDV transduction of cytokine-stimulated resting T cells. Resting T cells were cocultured in the presence of cytokines and 10 μM BrdU for 4 d and infected with HDV-EGFP for an additional 4 d while being maintained in continuous culture with fresh BrdU. T cells stimulated with anti-CD3 plus anti-CD28 antibodies were cultured, 3 d after activation, with 10 μM BrdU for 2 d. Cells were then permeabilized and stained with a PE-conjugated anti-BrdU antibody. (A) GFP expression and BrdU incorporation in cytokine-stimulated T cells. (B) BrdU staining of TCR-activated T cells.
Figure 6
Maintenance of naive phenotype of cytokine-stimulated and HDV-EGFP–transduced resting T cells. HDV-EGFP–infected T cells were cultured for 30 d in the presence of cytokines and stained with PE-conjugated anti-CD45RO antibody. Numbers displayed above FACS® analysis profiles are the percentage of positive cells in each quadrant.
Figure 7
Replication-competent CCR5 tropic HIV-1 can infect cytokine-activated resting T cells. Cytokine stimulation and HIV-1 infection was done as described in Fig. 4. Cells were fixed in 4% paraformaldehyde before FACS® analysis.
Figure 8
Expression of CCR5 on cytokine- or TCR-stimulated T cells. Purified resting CD4+ T cells were cultured with cytokines as described in Fig. 3. Cells were stained with PE-conjugated anti-CCR5 and FITC-conjugated anti-CD45RO antibodies.
Figure 9
Functional assessment of mCD28 expressed on human T cells. (A) Expression of mCD28 in sorted T cells 2 wk after transduction with HIV. (B) CD4+ and CD8+ human T cell lines transduced with wild-type (w+) or cytoplasmic domain–deleted (Δcyto+) mCD28 were stimulated 2 or 3 wk after the last activation with different concentrations of plate-bound anti-CD3 in the presence or absence of 1 μg/ml soluble anti-hCD28 or -mCD28 antibodies. Proliferation was measured after 2 d by [3H]thymidine incorporation.
Figure 10
IL-2 production by costimulation through mCD28 expressed on human T cells. IL-2 production was measured by titrating supernatants from cultures of CD4+ or CD8+ T cell lines that were stimulated with anti-CD3 and anti-CD28. Supernatants were collected after 36 h of stimulation and IL-2 was measured using the CTLL bioassay. 1 U of IL-2 is defined as half-maximal proliferation of CTLL. (A) IL-2 production by CD4+ T cell lines. (B) IL-2 production by CD8+ T cell lines that are negative for hCD28 expression as determined by FACS® analysis.
Similar articles
- Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
Mujib S, Jones RB, Lo C, Aidarus N, Clayton K, Sakhdari A, Benko E, Kovacs C, Ostrowski MA. Mujib S, et al. J Immunol. 2012 Apr 15;188(8):3745-56. doi: 10.4049/jimmunol.1102609. Epub 2012 Mar 14. J Immunol. 2012. PMID: 22422881 - Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages.
Auten J, Agarwal M, Chen J, Sutton R, Plavec I. Auten J, et al. Hum Gene Ther. 1999 May 20;10(8):1389-99. doi: 10.1089/10430349950018058. Hum Gene Ther. 1999. PMID: 10365668 - Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Zhou X, Cui Y, Huang X, Yu Z, Thomas AM, Ye Z, Pardoll DM, Jaffee EM, Cheng L. Zhou X, et al. Hum Gene Ther. 2003 Jul 20;14(11):1089-105. doi: 10.1089/104303403322124800. Hum Gene Ther. 2003. PMID: 12885348 - Disruption of the gamma c cytokine network in T cells during HIV infection.
Sirskyj D, Thèze J, Kumar A, Kryworuchko M. Sirskyj D, et al. Cytokine. 2008 Jul;43(1):1-14. doi: 10.1016/j.cyto.2008.03.001. Epub 2008 Apr 15. Cytokine. 2008. PMID: 18417356 Review. - Immune dysregulation and CD4+ T cell loss in HIV-1 infection.
Meyaard L, Miedema F. Meyaard L, et al. Springer Semin Immunopathol. 1997;18(3):285-303. doi: 10.1007/BF00813499. Springer Semin Immunopathol. 1997. PMID: 9089950 Review. No abstract available.
Cited by
- Imaging HIV-1 Nuclear Import, Uncoating, and Proviral Transcription.
Burdick RC, Duchon A, Hu WS, Pathak VK. Burdick RC, et al. Methods Mol Biol. 2024;2807:15-30. doi: 10.1007/978-1-0716-3862-0_2. Methods Mol Biol. 2024. PMID: 38743218 - HIV-1 uncoating requires long double-stranded reverse transcription products.
Burdick RC, Morse M, Rouzina I, Williams MC, Hu WS, Pathak VK. Burdick RC, et al. Sci Adv. 2024 Apr 26;10(17):eadn7033. doi: 10.1126/sciadv.adn7033. Epub 2024 Apr 24. Sci Adv. 2024. PMID: 38657061 Free PMC article. - Immunomodulation with IL-7 and IL-15 in HIV-1 infection.
Gunst JD, Goonetilleke N, Rasmussen TA, Søgaard OS. Gunst JD, et al. J Virus Erad. 2023 Sep 5;9(3):100347. doi: 10.1016/j.jve.2023.100347. eCollection 2023 Sep. J Virus Erad. 2023. PMID: 37767312 Free PMC article. - Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A, Paneerselvam N, Lawson BR. Khan A, et al. Clin Immunol. 2023 Oct;255:109741. doi: 10.1016/j.clim.2023.109741. Epub 2023 Aug 21. Clin Immunol. 2023. PMID: 37611838 Free PMC article. Review. - Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells.
Shapiro MR, Peters LD, Brown ME, Cabello-Kindelan C, Posgai AL, Bayer AL, Brusko TM. Shapiro MR, et al. J Immunol. 2023 Oct 1;211(7):1108-1122. doi: 10.4049/jimmunol.2200651. J Immunol. 2023. PMID: 37594278 Free PMC article.
References
- Mulligan RC. The basic science of gene therapy. Science. 1993;260:926–932. - PubMed
- Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 1993;217:581–599. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical